Evidence map›Paper›PMID 42604147›Full record

ArticleJTCVS open2026

National analysis of the incidence and prognostic importance of nodal metastases in atypical lung carcinoid tumors.

Adam B Sauer, Ntemena Kapula, Lillian Tsai, Douglas Z Liou, Irmina A Elliott, Mark F Berry

Abstract read
In one paragraph

Article in JTCVS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adam B SauerDepartment of Cardiothoracic Surgery, Stanford University, Stanford, Calif.
Ntemena KapulaDepartment of Cardiothoracic Surgery, Stanford University, Stanford, Calif.
Lillian TsaiDepartment of Cardiothoracic Surgery, Stanford University, Stanford, Calif.
Douglas Z LiouDepartment of Cardiothoracic Surgery, Stanford University, Stanford, Calif.
Irmina A ElliottDepartment of Cardiothoracic Surgery, Stanford University, Stanford, Calif.
Mark F BerryDepartment of Cardiothoracic Surgery, Stanford University, Stanford, Calif.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the relationship of atypical lung carcinoid (AC) tumor size, nodal involvement, and survival. Methods: Patients recorded in the National Cancer Database who underwent lobectomy or sublobar resection for lung AC between 2006 and 2022 were included. A multivariable logistic regression model was used to identify independent factors associated with lymph node involvement. Survival was assessed using the Cox proportional hazard model and Kaplan-Meier method. Results: A total of 1927 patients met the study's inclusion criteria. The incidence of overall node positivity was 33.4%. The incidence of positive pathologic nodes in patients who were clinically considered node-negative was 25.2%. Lymph node involvement was more likely with increasing tumor size, ranging from a rate of 19.1% in the subset of patients with subcentimeter-sized tumors to 45.9% with tumors larger than 7 cm. Increasing tumor size was associated with a higher risk of nodal involvement in a multivariable analysis. Positive nodes were associated with significantly worse survival in both Kaplan-Meier analysis (5-year survival, 71.7% vs 88.5%; Conclusions: Nodal involvement is a critical factor associated with survival for AC tumors of the lung and occurs at a high rate, even when tumors are very small. Lymph node evaluation at the time of AC resection should be considered regardless of tumor size to most accurately stage patients.

Indexed as

atypical carcinoidlung cancerlymph node metastasisnational databasetumor size

Identifiers

PMID42604147
PMCPMC13476998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.